Filing Details
- Accession Number:
- 0000950170-24-011880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-06 20:23:04
- Reporting Period:
- 2024-02-02
- Accepted Time:
- 2024-02-06 20:23:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1863127 | Tyra Biosciences Inc. | TYRA | Pharmaceutical Preparations (2834) | 831476348 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1880946 | Daniel Bensen | C/O Tyra Biosciences, Inc. 2656 State Street Carlsbad CA 92008 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-02 | 25,393 | $0.61 | 553,374 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-02 | 73,093 | $16.31 | 480,281 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-02 | 2,300 | $17.04 | 477,981 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-06 | 15,413 | $18.09 | 462,568 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-02 | 25,393 | $0.00 | 25,393 | $0.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 108,110 | 2030-01-26 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.91. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.
Billionaire Hedge Funds
